Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Novel GLP-1-based Medications for Type 2 Diabetes and Obesity (Endocrine Reviews)
Each unit = 0.01ml
Robert Gabbay, Chief Scientific and Medical Officer at the American Diabetes Association, has noted: "The distinction between treating obesity and treating diabetes with the same molecule reflects regulatory and insurance frameworks, not differences in the medicine itself." Efficacy Across Populations: What the Broader SURMOUNT and SURPASS Programs Show The SURMOUNT program extends beyond its first trial
EpiProfile 2.0: a computational platform for processing epi-proteomics mass spectrometry data
US$ 28.36
US$ 22.58
US$ 23.62
US$ 21.02
